Over the years, healthcare professionals have been concerned about the emergence and reappearance of certain infectious diseases, especially when associated with epidemics and severe health crises. In response to these new public health challenges, suitable epidemiological surveillance tools must be developed to manage infectious risks effectively. Moreover, the bacteria that cause infections often develop antibiotic resistance mechanisms, and the surveillance of these strains is instrumental in infection control efforts.
The added value of genome sequencing
When used as an epidemiological tool, whole genome sequencing will allow laboratories to obtain extremely precise information about bacteria believed to be involved in infection transmission or as the cause of outbreaks and epidemics. Sequencing will make it possible to establish a correlation between the different characteristics of an infectious agent to determine the chronology of transmission and monitor its spread.
This wealth of information will facilitate and speed up decisions by healthcare professionals in order to take effective measures to limit the spread of these pathogens.
In late 2015, bioMérieux and Illumina, a world leader in genomics, launched BIOMÉRIEUX EPISEQ®, an innovative next-generation sequencing (NGS) service dedicated to the epidemiological monitoring and control of healthcare-associated infections.